Weiss Multi-Strategy Advisers’s DexCom DXCM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,265	Closed	-$902K	–	149
2023 Q4	$902K	Sell	7,265 -65,779	-90%	-$6.72M	0.02%	444
2023 Q3	$6.82M	Buy	73,044 +11,668	+19%	+$1.32M	0.16%	172
2023 Q2	$7.89M	Buy	61,376 +39,618	+182%	+$4.79M	0.16%	189
2023 Q1	$2.53M	Sell	21,758 -14,785	-40%	-$1.66M	0.06%	389
2022 Q4	$4.14M	Sell	36,543 -53,948	-60%	-$5.92M	0.12%	256
2022 Q3	$7.29M	Buy	90,491 +54,810	+154%	+$4.64M	0.19%	165
2022 Q2	$2.66M	Sell	35,681 -43,903	-55%	-$4.01M	0.08%	338
2022 Q1	$10.2M	Buy	79,584 +31,584	+66%	+$3.45M	0.24%	147
2021 Q4	$6.44M	Buy	48,000 +1,420	+3%	+$204K	0.15%	194
2021 Q3	$6.37M	Sell	46,580 -4,136	-8%	-$522K	0.14%	212
2021 Q2	$5.41M	Buy	50,716 +556	+1%	+$53.4K	0.12%	250
2021 Q1	$4.51M	Sell	50,160 -13,840	-22%	-$1.3M	0.1%	275
2020 Q4	$5.92M	Sell	64,000 -20,152	-24%	-$1.8M	0.11%	236
2020 Q3	$8.67M	Sell	84,152 -14,444	-15%	-$1.51M	0.23%	143
2020 Q2	$9.99M	Buy	98,596 +10,596	+12%	+$948K	0.29%	108
2020 Q1	$5.92M	Buy	88,000 +2,000	+2%	+$124K	0.23%	144
2019 Q4	$4.7M	Sell	86,000 -34,000	-28%	-$1.61M	0.08%	312
2019 Q3	$4.48M	Sell	120,000 -59,600	-33%	-$2.32M	0.09%	271
2019 Q2	$6.73M	Sell	179,600 -10,800	-6%	-$339K	0.18%	132
2019 Q1	$5.67M	Buy	190,400 +2,400	+1%	+$84.3K	0.14%	183
2018 Q4	$5.63M	Buy	188,000 +34,000	+22%	+$1.08M	0.23%	117
2018 Q3	$5.51M	Sell	154,000 -26,000	-14%	-$806K	0.15%	182
2018 Q2	$4.27M	Sell	180,000 -20,000	-10%	-$424K	0.1%	245
2018 Q1	$3.71M	Sell	200,000 -80,000	-29%	-$1.18M	0.12%	226
2017 Q4	$4.02M	Buy	280,000 +20,000	+8%	+$260K	0.1%	225
2017 Q3	$3.18M	Buy	260,000 +100,000	+63%	+$1.77M	0.12%	234
2017 Q2	$2.93M	Buy	160,000 +40,000	+33%	+$739K	0.12%	232
2017 Q1	$2.54M	Sell	120,000 -40,000	-25%	-$781K	0.1%	239
2016 Q4	$2.39M	Buy	160,000 +20,000	+14%	+$354K	0.12%	180
2016 Q3	$3.07M	Sell	140,000 -5,800	-4%	-$129K	0.19%	164
2016 Q2	$2.89M	Sell	145,800 -162,200	-53%	-$2.76M	0.22%	140
2016 Q1	$5.23M	Buy	308,000 +20,000	+7%	+$334K	0.23%	122
2015 Q4	$5.9M	Sell	288,000 -12,000	-4%	-$250K	0.41%	57
2015 Q3	$6.44M	Sell	300,000 -140,000	-32%	-$3.12M	0.28%	71
2015 Q2	$8.8M	Sell	440,000 -46,400	-10%	-$815K	0.35%	84
2015 Q1	$7.58M	Sell	486,400 -113,600	-19%	-$1.72M	0.34%	82
2014 Q4	$8.26M	Sell	600,000 -40,000	-6%	-$490K	0.28%	74
2014 Q3	$6.4M	Sell	640,000 -60,000	-9%	-$613K	0.16%	158
2014 Q2	$6.94M	Hold	700,000	–	–	0.15%	159
2014 Q1	$7.24M	Sell	700,000 -300,000	-30%	-$3.1M	0.15%	181
2013 Q4	$8.85M	Sell	1,000,000 -280,000	-22%	-$2.22M	0.19%	151
2013 Q3	$9.03M	Sell	1,280,000 -220,000	-15%	-$1.39M	0.19%	143
2013 Q2	$8.42M	Buy	+1,500,000	New	+$7.18M	0.25%	135

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Weiss Multi-Strategy Advisers's DXCM Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of DexCom (DXCM) in Q1 2024, closing a stake of 7,265 shares — an estimated $902K sold.

Weiss Multi-Strategy Advisers first reported a position in DXCM in Q2 2013 and held it in 43 quarters. The position peaked at $10.2M in Q1 2022. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 7,265 DexCom shares in Q1 2024, an estimated $902K.
Weiss Multi-Strategy Advisers first reported a position in DexCom in Q2 2013 and held it in 43 quarters.
Weiss Multi-Strategy Advisers's DexCom position peaked at $10.2M in Q1 2022.
1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.